home / stock / pbd / pbd news


PBD News and Press, Invesco Global Clean Energy From 12/16/19

Stock Information

Company Name: Invesco Global Clean Energy
Stock Symbol: PBD
Market: NYSE

Menu

PBD PBD Quote PBD Short PBD News PBD Articles PBD Message Board
Get PBD Alerts

News, Short Squeeze, Breakout and More Instantly...

PBD - U.N. climate talks come to an end

Sparring for two weeks in Madrid at the annual UN climate summit, delegates from nearly 200 nations failed to strengthen targets to cut emissions or to create a global carbon-trading system, two main goals of the 2015 Paris accord. More news on: iShares S&P Global Clean Energy Index ...

PBD - EU agrees to go carbon neutral by 2050

Stepping up their fight against climate change, EU leaders have agreed to cut the bloc's greenhouse gas emissions to net-zero by 2050. More news on: Invesco Solar Portfolio ETF, VanEck Vectors Coal ETF, iShares S&P Global Clean Energy Index ETF, Top stock market news, Energy stocks n...

PBD - Protalix BioTherapeutics Announces 1-for-10 Reverse Stock Split

CARMIEL, Israel, Dec. 9, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ®...

PBD - COP25 centers on carbon offset market

Delegates from nearly 200 countries are gathering in Madrid for COP25 - the first big climate meeting since the U.S. declared it would pull out of the Paris accord. More news on: iShares S&P Global Clean Energy Index ETF, Invesco WilderHill Clean Energy Portfolio ETF, First Trust NAS...

PBD - Protalix BioTherapeutics Hosting Key Opinion Leader Meeting on PRX?102 Drug Candidate for the Treatment of Fabry Disease

CARMIEL, Israel, Nov. 27, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ...

PBD - New Jersey more than doubles offshore wind commitment

New Jersey plans to more than double its target for offshore wind energy production under an executive order signed today by Gov. Murphy. More news on: First Trust Exchange-Traded Fund II - First Trust Global Wind Energy ETF, iShares S&P Global Clean Energy Index ETF, Invesco Global ...

PBD - EU ends funding for fossil fuel projects

Cutting €2B of yearly investments, the European Union will stop funding oil, natural gas and coal projects at the end of 2021 as it aims to become the first climate-neutral continent. More news on: iShares S&P Global Clean Energy Index ETF, VanEck Vectors Low Carbon Energy ETF...

PBD - Protalix BioTherapeutics to Release Third Quarter 2019 Financial Results and Business Update on November 7, 2019

CARMIEL, Israel, Oct. 29, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProC...

PBD - Westport Fuel Systems: The Stock Holds After A Scandal

I have not written a piece on Westport Fuel Systems ( WPRT ) since early July when the price of the shares was at $2.89. Since then, WPRT has traded in a range from $2.35 to $3.27. Since the midpoint of the trading range is around where the stock was trading in early July, there has not been m...

PBD - Protalix BioTherapeutics and Chiesi Group Complete Enrollment in the Third Phase III Clinical Trial of pegunigalsidase alfa (PRX?102) for the Treatment of Fabry Disease

CARMIEL, Israel, Sept. 24, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx...

Previous 10 Next 10